ESCCAP Guideline 2 Ringworm Control in Dogs and Cats
Background ESCCAP (European Scientific Counsel Companion Animal Parasites) is an independent, non-profit making organization whose aim is to develop guidelines for the control and treatment of parasites (including pathogenic fungi) in pet animals. The guidelines are developed to protect the health of pets, enhance the safety of the public and preserve the bond between pets and people. The longterm goal for ESCCAP is that parasites are no longer an issue for pets or humans across Europe. There is great diversity in the parasites and their importance across Europe. ESCCAP guidelines summarise the different situations within Europe, highlighting important differences between parasites and between different parts of Europe where necessary, and recommend specific control measures. ESCCAP believes that: § Veterinarians and pet owners must take measures to protect pets from parasitic and fungal infections. § Pet travel has the potential to change epidemiological situations with export or import of non-enzootic parasite species, therefore veterinarians and pet owners must protect the pet population from risks associated with travel and its consequences. § Veterinarians, pet owners and physicians should work together to reduce the risks associated with zoonotic transmission of parasitic or fungal diseases. § Veterinarians can and should give guidance to the pet owner regarding infection risk and risk of disease caused by different parasites and measurements against them. § Veterinarians should inform the pet owner about parasites and enable them to act responsibly for their pet’s life and the pets and other animals and people in their communities. § Wherever appropriate, veterinarians should undertake appropriate diagnostic tests to establish parasite infection status. To assist in this process, ESCCAP produces each guideline in two formats: 1) Full: detailed for veterinary surgeons and veterinary parasitologists and mycologists; 2) Summarised: for veterinarians and pet owners. Both versions of the guideline can be found at /. Various guidelines for treatment and control of parasitic or fungal infections in companion animals have been implemented in other countries such as USA by organizations such as the CAPC. However, to date no single comprehensive guideline for Europe with its diverse parasite spectrum has been developed.
 Ringworm Control in Dogs and Cats
IntroductionDermatophytes are filamentous fungi which are able to use keratin as a source of carbon. Some of these organisms are true parasites; they develop in skin and hair and cause cutaneous lesions. The corresponding disease is called ringworm or dermatophytosis and is recognized as one of the most common infectious dermatosis in dogs and cats. More than 20 different dermatophyte species have been isolated from pet carnivores. Some of these dermatophytes are more important than others due to their prevalence and their zoonotic potential. In Europe, the most commonly isolated pathogens are Microsporum canis (especially in cats), Microsporum gypseum, Microsporum persicolor and Trichophyton mentagrophytes (Table 1). This guideline aims to give an overview of these keratinophilic fungi, their significance and, importantly, suggests rational control measures in order to treat pet carnivores and prevent animal and/or human infection. The guideline is divided into five sections I. Consideration of pet health and lifestyle factors II. Control of ringworm in animals III. Environmental control of dermatophyte transmission IV. Owner considerations in preventing zoonotic disease V. Staff, pet owner and community education

I. Consideration of pet health and lifestyle factors
The presence or absence of dermatophytosis is influenced by a vast number of factors relating to the animals themselves, environmental issues and crowding of animals. Some factors may dictate more intensive monitoring and/or treatment, while others may suggest a less aggressive approach. When recommending a management program for ringworm, veterinarians should consider the following elements: Animal Kittens, puppies and geriatric animals are at greater risk than other animals. Pregnant and lactating bitches and queens are frequently infected by dermatophytes and may transmit the infection to the offspring. In pregnant animals, the number of available antifungal drugs is limited. Any breed is susceptible to the infection. However, both Yorkshire Terriers and Persian cats have a recognized predisposition to ringworm. Familial predispositions have been suggested in cats. Any debilitating disease may play a role by making dogs and cats more susceptible to dermatophyte infection. This kind of diseases should be systematically identified and, if possible, treated before the onset of specific antifungal treatments. In cats, the association between retroviral (FIV or FeLV) and ringworm is still a matter of controversy. In one study, ringworm was three times more common in FIV-infected cats whereas in another, no association was evidenced between FIV or FeLV and dermatophyte infection. Ectoparasites (such as fleas, ticks or Cheyletiella mites) or pruritus from secondary infections may be sources of cutaneous micro trauma that can predispose dogs and cats to ringworm.
Environment Increased warmth and humidity are predisposing factors to ringworm. Cats living in catteries or shelters, stray or feral cats and cats living with other cats or dogs may be at greater risk of acquiring dermatophytes and may require special consideration. Dogs in kennels, living outdoors, stray or hunting dogs may be at greater risk of acquiring dermatophytes and may require special consideration.
Travel
Cats and dogs, which regularly attend shows or field trials are predisposed to ringworm. Common dermatophyte species (M. canis, M. gypseum, M. persicolor and Trichophyton mentagrophytes) have a very wide distribution in all European countries. Ringworm is probably more prevalent in underdeveloped countries or in areas in which there are large populations of free-roaming dogs and cats.

II. Control of ringworm in animals II. 1. Diagnosis Dermatophytes invade hair shafts and cornified epithelium. As a consequence, ringworm usually presents as patchy areas of alopecia on the face, ears or forelegs. The condition is typically considered as nonpruritic but some animals (especially adult cats) may be moderately to intensely pruritic. Uncommon clinical manifestations include folliculitis, feline miliary dermatitis, feline acne, pemphigus-like syndromes and pseudomycetoma. Ringworm should be considered in the differential diagnosis of many skin diseases and diagnostic aids are systematically required. Examination of the haircoat with an ultraviolet lamp (Wood's lamp) is a good screening method for ringworm in dogs and cats. When exposed to the light, hairs invaded by M. canis glow yellow green. Hairs infected by other dermatophyte species (T. mentagrophytes, M. persicolor or M. gypseum) never fluoresce and some topical medications may destroy fluorescence. Thus a negative Wood's lamp examination does not rule out ringworm. Microscopic examination of hairs is a very useful diagnostic method. Hairs should be collected through skin scrapings or during Wood's lamp examination. After digestion with a clearing solution (such as KOH or chlorolactophenol), infected hairs present as enlarged and swollen structures with a rough and irregular surface. The hair surface typically demonstrates clusters or chains of fungal spores (2-4 µm for M. canis). Mycological culture remains the most reliable technique for confirming ringworm in dogs and cats. Sample collection may be obtained by scraping the cutaneous lesions, plucking hairs (under Wood's light) or brushing the haircoat with a sterile toothbrush or a little piece of carpet. Several media are suitable for mycological cultures. Since the development of a specific culture medium proposed by Taplin et al. in 1969, Dermatophyte Test media (DTM) became very popular among small laboratories and are regularly used in veterinary medicine. However, only a very few attempts have been made to evaluate the performance of such media with material obtained from animals. A recent investigation demonstrated that the rapidity of color change was related to the incubation temperature and to the number of infected hairs deposited on DTM (Guillot et al. 2001). The risk of false positive results was identified as another problem associated with the use of DTM. For these reasons, the use of DTM is not recommended for the diagnosis of animal ringworm. The material collected from the animals should be sent to a laboratory with an expertise in veterinary Mycology. In the laboratory, specific identification is made by microscopic examination of the fungal colonies. II. 2. Treatment procedures In most cases, immune response is sufficient to control the spread of the cutaneous lesions and ringworm is considered to be a self-limiting disease. However, antifungal treatment should be systematically recommended for two main reasons: to shorten the course of the infection and to reduce dissemination of infective material into the environment. Infective material is composed of small pieces of hair covered by microscopic fungal spores (called arthroconidia). Infective material is easily spread and can remain viable in the environment for up to 18 months under optimal conditions of temperature and humidity. Infected animals (with or without clinical signs) and contaminated environments represent a longterm exposure to other animals and owners. Systemic antifungals are supposed to contribute to speed the resolution of the infection whereas topical antifungals are required to reduce the risk of transmission and the environmental contamination. Current treatment recommendations stem from both in vivo and in vitro studies. Important therapeutic measures include: · The combination of systemic and topical treatment. Conventional systemic treatment relies on oral antifungal drugs, principally griseofulvin. The micronized formulation of griseofulvin should be administered orally at 25 mg/kg twice daily and with fatty meals. In some circumstances newer antifungal drugs may be valuable (Table 2). Careful attention must be paid to the potential adverse effects of most systemic antifungal drugs. For adjuvant topical treatment, many products have been proposed (Table 3). The decision to use topical therapy should be based upon the owner’s ability and willingness to pour or sponge the product over the entire hair coat of the infected animal. Spot treatment of lesions is not recommended. The frequency of topical treatment should be at least twice a week.
· The appropriate length of treatment. The general recommendation is to culture the animal once a month during treatment and to stop antifungal administration after two negative cultures. Three negative results are preferred when multiple cats are involved. When mycological follow up is not possible, combined systemic and topical treatment should be continued for at least 10 weeks. If lesions persist after 8 weeks of treatment, veterinarians should suspect (i) that the treatment is not correctly administered by the owner (ii), that an underlying disorder is interfering with the normal action of the immune system, (iii) that the animal has a genetic background that makes it more sensible to dermatophyte infection. The presence of resistant strains is regularly suspected but resistance of dermatophytes to antifungal drugs has been proved in only a very few instances and this hypothesis should not be considered as the most likely in cases of treatment failure. · The clipping of the hair coat, especially in severely infected animals, long-haired cats or in multi-animal households. Clipping makes topical therapy application easier and allows for better penetration of the drug. In households with one or two pets, spot clipping of lesions may be enough. Clipping must be performed carefully and in an area that can be easily disinfected (see later). In cats, clipping the coat may require sedating. · The complete separation of infected animals from non-infected ones. · Hygiene measures especially environmental decontamination (see section III). All dermatophyte species have a similar sensitivity to antifungal drugs currently available. As a consequence, the specific identification of the dermatophyte is not required for the choice of the drugs. Identification of the dermatophyte may be useful for a better understanding of the epidemiology of the infection and for preventing a new contamination. In catteries and animal shelters, dermatophyte infection is very difficult to eradicate and creates a significant health hazard for people in contact with the animals. The cost of antifungal drugs and the reluctance of the breeders to admit that their colony is infected usually account for the noncompliance with treatment recommendations. Most recommendations for the control of ringworm in catteries are based on the concept of a total treatment program, which associates the use of reliable diagnostic tools, both topical and systemic treatment of all the cats and strong environmental decontamination procedures. Interruption of breeding programs and show campaigns may also be recommended.
II. 3. Prevention Although the risk of dermatophyte infection is greatest for puppies, kittens, old or debilitated animals, the infection is not strictly age- or health status-related, and so the risk continues throughout life. Therefore consideration should be given to provide all dogs and cats with appropriate dermatophyte control throughout their lives. The contact with infected animal or contaminated environments represent the major risk of infection. As a consequence, the best way to avoid infection is to prevent this contact. This prophylactic strategy is very simple but not always feasible because infected animals do not systematically express obvious clinical signs. Asymptomatic carriers are frequently observed in feline populations. These animals may correspond to mechanical carriers or truly infected cats that will develop clinical signs in a few days or weeks. To protect animals, the use of antifungal drugs has been proposed: - Oral antifungal drugs were not proved to be appropriate. Carefully controlled studies in humans demonstrated that oral griseofulvin has no prophylactic action. Recent investigations showed that oral lufenuron may delay the initial establishment or progression of ringworm in cats reflecting some inhibitory effect, but lufenuron did not prevent infection.
- Topical treatments are probably more valuable. The general recommendation is to apply an antifungal shampoo or rinse on the entire body of any dog and cat, which has been in contact with an infected animal or a contaminated area. Under optimum conditions, infective fungal spores germinate within 6 hours on the skin of pet carnivores, so the preventive application of antifungal drug should be performed in the day following the presumptive contamination.
Efforts in developing fungal vaccines to prevent ringworm in dogs and cats continue. The first commercially available vaccine was licensed for use in cats in the USA in 1994 (Fel-O-Vax MC-K®, Fort Dodge). Other products are currently commercialized in some European countries in Europe. These are live vaccines that may contain different dermatophyte species (Microsporum canis and Trichophyton mentagrophytes for example). Several investigations showed that these vaccines were not protective against challenge exposure, but they could be associated with a temporary reduction in the clinical signs of ringworm. As a consequence, the use of these vaccines is not recommended for a longterm prevention of ringworm in dogs and cats.
In dog and cat breeding units as well as in animal shelters, the main risk is represented by the introduction of an infected animal. Newbury et al. (2007) recently described a management plan that should be recommended for the longterm prevention of ringworm in any dog and cat colony. This plan includes screening, monitoring and treatment procedures. At the point of entry, animals should be carefully examined, vaccinated, treated for ectoparasites and intestinal worms (see Guideline 1). The animals are also screened for ringworm via Wood’s lamp examination and fungal culture. Animals should then be transferred to a quarantine ward until the results of the tests. The presence of an annex building for the treatment of animals with ringworm is preferable. The most interesting information provided by Newbury et al. is that treatment decision should be made according to fungal culture results. Colony-forming unit count combined with clinical examination can help to differentiate mechanical carriers from infected animals. Mechanical carriers should be treated with one topical application of antifungal drug before introduction within the colony. Infected animals are kept in quarantine and treated by a combination of systemic and topical antifungal drugs. These animals are not introduced in the colony before two negative fungal cultures are obtained.
III. Environmental control of dermatophyte transmission Dermatophytes are transmitted through microscopic spores, which are formed via fragmentation of fungal hyphae on the skin or infected hair. The presence of these spores in the environment increases the risk of exposure, reinfection and prolonged treatment of animals. Decontaminating the environment involves thorough cleaning and regular disinfectant application. Spores and fragment of infected hairs may be mechanically eliminated by a regular vacuum cleaning of the surfaces where animals lie on. Recent studies demonstrated that undiluted bleach and 1% formalin were able to kill all dermatophyte spores in the environment (however, because of its caustic properties, undiluted bleach is not recommended for use in households). Sodium hypochloride solution at 1:10 dilution and enilconazole solution were also proven to be active. All other disinfectants demonstrated poor efficacy. An enilconazole smoke fumigant formulation is available in most European countries. Brushes, combs rugs and cages should be carefully washed and if possible, treated with a solution of enilconazole or 1:10 dilution of household bleach. Vehicles used for transporting the animals should be also treated. In animal shelters or breeding, contact plates can be used to sample environmental surfaces and check that disinfection has been correctly performed. Commercial swifer clothes may also be used to monitor the environment for contamination.
IV. Owner considerations in preventing zoonotic diseases Important preventive measures for pet owners include: · practicing good personal hygiene (dermatophytes are zoonotic) · controlling dermatophyte infection through regular diagnostic testing and/or repeated proper treatments (see under II, 2). · preventing infection by reducing where ever possible the pet from acquiring infection · minimizing exposure of children in particular to potentially contaminated environments or infected animals People in contact with infected animals should be advised of the risks and made aware that there are specific risk groups in the society. This information should be made available through physicians and veterinarians at anybodies request without obtaining a medical history of the client and his/her family. In this respect special care should be taken in case of: · immunocompromised individuals such as: pregnant women, elderly people, HIV-infection patients, people undergoing chemotherapy, organ transplantation, or treatment for autoimmune diseases · other susceptible groups: babies and toddlers, mentally disabled persons, people with specific occupational risks

V. Staff, pet owner and community education Protocols for the control of dermatophyte infection should be communicated to veterinary and para-veterinary staff and consistently applied. Awareness of dermatophyte infection, including clinical manifestations in people and particularly children should be created in the medical profession through information brochures. Cooperation between the medical and veterinary profession ought to be institutionalised and its benefits underlined in case of zoonosis. Pet owners should be informed about the potential health risks of dermatophyte infection, not only to themselves but also to family members and all people living regularly in contact with their pets. Brochures in veterinary practices, pet shops, posters or specific websites are useful tools to achieve this. Responsible dog and cat ownership can remove public health concerns. Additional information and resource materials can be obtained at www.esccap.org Further Reading Ben-Ziony Y, Arzi B, 2000. Use of lufenuron for treating fungal infections of dogs and cats: 297 cases (1997-1999). JAVMA 217: 1510-1513 Colombo S et al, 2001. Efficacy of itraconazole as combined continuous/pulse therapy in feline dermatophytosis: preliminary results in nine cases. Vet Dermatol 12: 347-350 DeBoer DJ et al, 2003. Effects of lufenuron treatment in cats on the establishment and course of Microsporum canis infection following exposure to infected cats. JAVMA 222: 121-122 Grooters AM, Taboada J, 2003. Update on antifungal therapy. Vet Clin North Am Small Anim Pract 33: 749-758 Guillot J, Latié L, Deville M, Halos L, Chermette R. 2001. Evaluation of the dermatophyte test medium RapidVet-D. Vet Dermatol 12: 123-127 Guillot J et al, 2002. Evaluation of the efficacy of oral lufenuron combined with topical enilconazole for the management of dermatophytosis in catteries. Vet Rec 150: 714-718 Mancianti F et al, 1998. Efficacy of oral administration of itraconazole to cats with dermatophytosis caused by Microsporum canis. JAVMA 213: 993-995 Moriello KA, DeBoer DJ, 1995. Efficacy of griseofulvin and itraconazole in the treatment of experimentally induced dermatophytosis in cats. JAVMA 207: 439-444 Moriello KA, 2004. Treatment of dermatophytosis in dogs and cats: review of published studies. Vet Dermatol 15: 99-107 Newbury S, Moriello K, Verbrugge M, Thomas C.2007. Use of lime sulphur and itraconazole to treat shelter cats naturally infected with Microsporum canis in an annex facility: an open field trial. Vet Dermatol 18: 324-331 Perrins N, Bond R, 2003. Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine. Vet Dermatol 14: 99-102 Rycroft AX, Mclay C, 1991. Disinfectants in the control of small animal ringworm due to Microsporum canis. Vet Rec 129: 239-241 Rochette F et al, 2003. Antifungal agents of use in animal health; practical applications. J Vet Pharmacol Ther 26: 31-53 Shelton GH et al, 1990. Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus. J Vet Intern Med 4: 317-319 
Table 1: Characteristics of major dermatophyte species infecting dogs and cats in Europe

Table 2:Systemic antifungal drugs for th treatment of ringworm in dogs and cats 
Table 3: Topical antifungal drugs for the treatment of ringworm in dogs and cats 


|